RxDoctor Payments Data

Robert Wood, MD

Family Medicine · Madisonville, KYNPI 1194822817

Payments from drug & device makers

$2,605in general payments, 2019–2025

Across 175 payments — averaging $14.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$544
  • Pfizer$487
  • Amgen$341
  • GSK$143
  • Johnson & Johnson$128
  • Novo Nordisk$118
  • plus $844 from 27 others

What the payments were for

  • Food & beverage$2,597100%
  • Education$80%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,605 in reported general payments places this provider in the 70th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$1,433
Medicare patients
30
Services billed
45

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$124,026
EliquisApixaban94$67,303
TrulicityDulaglutide46$57,792
MounjaroTirzepatide52$55,591
JanuviaSitagliptin Phosphate66$48,993
JardianceEmpagliflozin42$39,993
Trelegy ElliptaFluticasone/Umeclidin/Vilanter58$36,797
XareltoRivaroxaban32$26,094
LinzessLinaclotide26$22,869
Spiriva RespimatTiotropium Bromide30$21,920
VraylarCariprazine Hcl12$17,077
Breo ElliptaFluticasone/Vilanterol22$14,190
Albuterol Sulfate HfaAlbuterol Sulfate391$13,813
SymbicortBudesonide/Formoterol Fumarate37$11,018
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$10,160

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$118$124,02695 claims
Lilly USA, LLCTrulicity, Mounjaro$544$113,38398 claims
PfizerEliquis, Celebrex$487$73,654107 claims
Boehringer IngelheimJardiance, Spiriva Respimat$13$61,91372 claims
GSKTrelegy Ellipta, Breo Ellipta, Incruse Ellipta$143$59,26198 claims
MerckJanuvia$29$48,99366 claims
AbbVieLinzess, Vraylar, Savella$97$46,25964 claims
AstraZenecaSymbicort, Breztri Aerosphere, Nexium$75$31,24175 claims
Johnson & JohnsonXarelto$128$26,09432 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Madisonville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →